OPENING A GLP-1 AND METABOLIC PROGRAM IN CHARLESTON: SOUTH CAROLINA'S EXTRA REGISTRATIONSSouth Carolina layers a state drug-control registration and a telemedicine statute of its own on top of the usual licensing, and it standardizes municipal business licenses across the state. This page is not legal advice; it is the agenda for South Carolina counsel.

Educational overview · Approx. 9 min read · illustrative, not advice

South Carolina layers a state drug-control registration and a telemedicine statute of its own on top of the usual licensing, and it standardizes municipal business licenses across the state. This page is not legal advice; it is the agenda for South Carolina counsel.

The supply question is the live risk in this category, everywhere including Charleston

Any program built around GLP-1 medications has a sourcing decision, and that decision is under active federal change. FDA removed tirzepatide from its shortage list in December 2024 and declared the injectable semaglutide shortage resolved on February 21, 2025, with enforcement discretion for 503A compounding pharmacies ending April 22, 2025 and for 503B outsourcing facilities on May 22, 2025.

It went further. On April 30, 2026 FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulk drug substances list, finding no clinical need for outsourcing facilities to compound them from bulk substance and expressly rejecting affordability and insurance access as constituting clinical need. The comment period was extended, with comments due July 30, 2026. FDA has also stated that a compounded product with the same active ingredient is not the drug FDA reviewed and approved, and that it does not evaluate specific compounded products for safety, effectiveness, manufacturing quality or consistency.

That is a durability risk for any business model that quietly depends on one supply path. It is not a South Carolina issue, but it lands on a Charleston build the same as anywhere. Atlas provides no medical services, employs no clinicians and makes no efficacy claim about any medication or supplement; sourcing decisions belong to the separately licensed medical entity.

Question one: South Carolina's regulator is inside a labour agency

The South Carolina Board of Medical Examiners sits under the South Carolina Department of Labor, Licensing and Regulation, alongside the South Carolina Board of Nursing. If you are used to a health-department-hosted board, the filing paths and portals will not be where you expect them.

Ask counsel which LLR boards your model touches and what each requires at entity level as distinct from individual level. Entity formation itself is filed with the South Carolina Secretary of State.

The compliance surface around advertising, refunds and program claims is separate again and applies regardless of how the medical entity is structured, which is why compliance basics for wellness businesses belongs in the reading order before your first campaign, not after.

Question two: the state controlled substance registration, and the agency that changed names

This one has a citation you can hold. S.C. Code Section 40-47-37 requires a licensee to “maintain a controlled substances registration with South Carolina's Bureau of Drug Control if prescribing controlled substances.” The Bureau now sits inside the South Carolina Department of Public Health, successor to the former Department of Health and Environmental Control, so older guidance still names an agency that no longer holds the function.

Ask your South Carolina counsel whether your prescriber arrangement triggers that state registration on top of federal DEA registration, and whether it reaches an out-of-state clinician working into Charleston. Confirm the issuing body, fee and renewal cycle with the DPH Bureau of Drug Control directly. This is a small item that stalls builds because everyone assumes the reference they are reading is current.

Federal registration is the more settled part: DEA set the practitioner fee at 888 dollars per three-year term in its 2020 fee rule, codified at 21 CFR 1301.13.

Question three: South Carolina has its own telemedicine statute

South Carolina carries a telemedicine provision inside its medical practice act at Section 40-47-37, plus a telehealth chapter, Title 40 Chapter 42, added by the Telehealth and Telemedicine Modernization Act, 2024 Act No. 120, effective March 11, 2024. The statute is explicit about scheduled drugs: “Schedule II-narcotic and Schedule III-narcotic prescriptions are not permitted except” in listed instances such as hospital-based care and hospice.

Ask your South Carolina counsel whether a remote-first metabolic program is consistent with how Section 40-47-37 and Chapter 42 treat establishing the physician-patient relationship and prescribing remotely, whether any medication on your service list is a scheduled controlled substance, and what changes if one is added later. Confirm the text with the Board of Medical Examiners: amending bills were still moving in the 2025-2026 session.

How the program is structured for members, and what it is honestly permitted to say about itself, are separate design problems. A medspa weight loss program integration is a common Charleston starting point and raises its own questions about who may perform what.

Ask Atlas to put this in writing: whether the Atlas program scope as delivered includes any controlled substance category, or is limited to non-scheduled medications and non-prescription support

Question four: nurse practitioner practice agreements and supervision limits

South Carolina routes advanced practice nursing through a written practice agreement rather than independent practice. Section 40-33-34 requires the agreement and defines the physician as “readily available” when able “to be contacted either in person or by telecommunications or other electronic means.” A 2018 Maynard Nexsen client alert describes a further cap on the physician side, six full-time-equivalent advanced practice nurses and physician assistants combined. Treat that figure as INFERENCE.

Ask your South Carolina counsel how many advanced practice clinicians one physician relationship may cover today, and confirm it with the Board of Nursing and the Board of Medical Examiners. Whatever the number is, it caps how far one physician relationship stretches. Model your staffing to the answer rather than to your ambition.

Sourcing, staffing and program design interact. How supplement supply chains work is the piece to read before you decide what your Charleston program hands a member at the end of the visit.

Question five: the Charleston business license layer is unusual and standardized

South Carolina standardized municipal business licensing by statute. Section 6-1-400 provides that “a business license must be issued to a taxpayer for a twelve-month period beginning May first and ending April thirtieth,” computed on gross income, using the standardized class schedule the Municipal Association of South Carolina builds from NAICS codes. The City of Charleston's Revenue Collections page states its annual fee is based on gross income collected inside the city the previous year.

Ask the City of Charleston Revenue Collections Division which class your business falls into, and ask counsel whether a second license applies for a second location or for Charleston County. Confirm state tax obligations with the Department of Revenue or your accountant. Nothing here is a rate schedule or a tax opinion.

Because the license is calculated on gross income, your bookkeeping needs to produce that figure cleanly from day one. That is a systems decision, and one of the operational playbook items an Atlas build hands over.

What Atlas licenses, and the terms that make it a license

Atlas Metabolic licenses a complete white-label metabolic-health business build: telehealth stack, ordering system, member AI coaching, brand kit and operational playbooks, delivered as one build. Clinical care is delivered by a separately licensed medical entity that you establish with your own counsel. Atlas has no clinicians and renders no care.

The terms are the differentiator: a one-time license fee, zero percent of partner revenue, no ongoing partner fees and no assigned exclusive geography. Franchises sell territory; Atlas does not sell geography at all, so a Charleston market is a decision rather than a boundary. The license fee is one-time. It carries 0% of revenue and no ongoing partner fees. The figure is not published anywhere, by design — it is disclosed in full on the fit call, where it can be put next to what it covers instead of floating on its own.

Bring your counsel's answers on drug-control registration, the telemedicine statute and the practice agreement cap to the apply page. If you want a coastal metro read for comparison, the Miami metabolic wellness buildout brief is the closest published neighbour in structure.

What this page is not

This page is general commentary from a company that is not a law firm. Atlas Metabolic does not practise law or medicine, provides no medical services and employs no clinicians. Nothing here is legal, tax or medical advice, and reading it creates no attorney-client relationship.

Regulation in this area changes, and it varies by structure: the same statute lands differently on an in-person clinic, a remote-first program and a management arrangement. Where this page can quote a statute or an agency it names and links it; where it cannot, it asks a question instead of stating an answer.

Every question above belongs to your own healthcare counsel licensed in South Carolina, working from the Board of Medical Examiners, the Board of Nursing, the Department of Public Health and the City of Charleston. Verify anything here before relying on it.

FREQUENTLY ASKED QUESTIONS.